Development of multi-criteria decision analysis (MCDA) framework for off-patent pharmaceuticals - an application on improving tender decision making in Indonesia.
Andras InotaiDiana BrixnerNikos ManiadakisIwan DwiprahastoErna KristinAgus PrabowoAlfi YasminaSigit PriohutomoBertalan NémethKalman WijayaZoltan KaloPublished in: BMC health services research (2018)
According to the pilot policy workshop, other criteria apart from price need to be strengthened in the tendering process. The introduction of additional criteria for OPP procurement in an MCDA framework creates incentives for manufacturers to invest into improved manufacturing standards, equivalence proof, product quality, reliability of supply or even additional real-world data collection, which ultimately may result in more health gain for the society.